Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Well, that's good
Covers the 15 August 2025 FDA approval of Tonix Pharmaceuticals' Tonmya (TNX-102 SL sublingual cyclobenzaprine) - the first new Read the full review Neuroscience 1 May 2026 Dihexa for Multiple Sclerosis (MS): Cognitive Impairment, Remyelination & the 2026 UK Review Can Dihexa help MS cognitive impairment or remyelination
Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis
Food, Nutrition, and Health Amy Chow, RD (BC Dietitians Team) References Brunton, S
Collective Impact: The participant group achieved a cumulative weight loss of 2,732 kg
A., Claggett, B
US$ 28.52
US$ 22.02
US$ 21.34
US$ 29.67
US$ 22.80
US$ 26.94
US$ 28.24
